Bausch Health Companies Overview
Bausch Health Companies Target Price
Analysts' 12-month price predictions for BHC.
Get informed when a big investor buys or sells
+ FollowShare Price
$4.99
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-01-07 | Truist FinancialLes Sulewski | $8 |  60.3% upside |  |
| 2025-12-08 | BarclaysGlen Santangelo | $8 | 60.3% upside | |
| 2024-10-23 | RBC CapitalDouglas Miehm | $10 | 100.4% upside | |
| 2024-07-25 | Truist FinancialLes Sulewski | $7 | 40.3% upside | |
| 2024-07-10 | Raymond JamesMichael Freeman | $8 | 60.3% upside | |
| 2024-04-29 | Piper SandlerDavid Amsellem | $9 | 80.4% upside | |
| 2024-04-23 | RBC CapitalDoug Miehm | $11 | 120.4% upside | |
| 2024-04-11 | JefferiesGlen Santangelo | $16 | 220.6% upside | |
| 2024-04-05 | RBC CapitalDoug Miehm | $12 | 140.5% upside | |
| 2022-09-09 | Piper Sandler | $6 | 20.2% upside | |
| 2022-07-26 | RBC Capital | $12 | 140.5% upside | |
| 2022-05-13 | RBC Capital | $17 | 240.7% upside | |